Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 21.46% vs 22.39% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 1,291.83% vs -115.91% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,515.20",
          "val2": "1,247.50",
          "chgp": "21.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "461.50",
          "val2": "-21.90",
          "chgp": "2,207.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "2.30",
          "chgp": "30.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "423.10",
          "val2": "-35.50",
          "chgp": "1,291.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "304.60%",
          "val2": "-44.00%",
          "chgp": "34.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -32.81% vs -11.44% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.72% vs 128.68% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,858.30",
          "val2": "7,230.90",
          "chgp": "-32.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,038.50",
          "val2": "890.70",
          "chgp": "16.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.80",
          "val2": "42.20",
          "chgp": "-55.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-117.50",
          "val2": "-113.80",
          "chgp": "-3.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,110.70",
          "val2": "2,215.20",
          "chgp": "-4.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "188.00%",
          "val2": "105.40%",
          "chgp": "8.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,515.20

1,247.50

21.46%

Operating Profit (PBDIT) excl Other Income

461.50

-21.90

2,207.31%

Interest

3.00

2.30

30.43%

Exceptional Items

0.00

0.00

Consolidate Net Profit

423.10

-35.50

1,291.83%

Operating Profit Margin (Excl OI)

304.60%

-44.00%

34.86%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 21.46% vs 22.39% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 1,291.83% vs -115.91% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,858.30

7,230.90

-32.81%

Operating Profit (PBDIT) excl Other Income

1,038.50

890.70

16.59%

Interest

18.80

42.20

-55.45%

Exceptional Items

-117.50

-113.80

-3.25%

Consolidate Net Profit

2,110.70

2,215.20

-4.72%

Operating Profit Margin (Excl OI)

188.00%

105.40%

8.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -32.81% vs -11.44% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -4.72% vs 128.68% in Dec 2024

All Annual Results